Clinical Scorecard: Z Optics Reports 6-Month Data for Z+ Virtual Aperture IOL
At a Glance
| Category | Detail |
|---|---|
| Condition | Intraocular Lens Implantation |
| Key Mechanisms | Monofocal platform with a geometric virtual aperture zone that reshapes light. |
| Target Population | Patients undergoing cataract surgery requiring intraocular lens implantation. |
| Care Setting | Clinical study presented at the European Society of Cataract and Refractive Surgeons (ESCRS) |
Key Highlights
- 100% of eyes with the third-generation lens achieved uncorrected distance vision of 20/32 or better.
- 92% achieved uncorrected near vision of 20/32 or better.
- No serious adverse events reported; all patients free of halos.
- 79% of patients reported no glare; corneal endothelial cell density maintained.
- Mean uncorrected acuity under mesopic conditions was 20/25 at distance.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
43 patients (86 eyes) implanted with Z+ IOL.
Z+ IOL provides a continuous range of vision from near to far without halos and glare.
Clinical Best Practices
- Consider Z+ IOL for patients seeking multifocal visual acuity with monofocal clarity.
- Monitor corneal endothelial cell density post-implantation.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.